000 01269 a2200313 4500
005 20250518051539.0
264 0 _c20200707
008 202007s 0 0 eng d
022 _a2224-6614
024 7 _a10.1016/j.jfda.2018.12.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Meng-Ting
245 0 0 _aRisk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease.
_h[electronic resource]
260 _bJournal of food and drug analysis
_c07 2019
300 _a657-670 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdministration, Inhalation
650 0 4 _aBronchodilator Agents
_xadministration & dosage
650 0 4 _aCardiovascular Diseases
_xcomplications
650 0 4 _aHumans
650 0 4 _aObservational Studies as Topic
650 0 4 _aPulmonary Disease, Chronic Obstructive
_xdrug therapy
650 0 4 _aRisk Factors
700 1 _aLai, Jyun-Heng
700 1 _aTsai, Chen-Liang
700 1 _aLiou, Jun-Ting
773 0 _tJournal of food and drug analysis
_gvol. 27
_gno. 3
_gp. 657-670
856 4 0 _uhttps://doi.org/10.1016/j.jfda.2018.12.006
_zAvailable from publisher's website
999 _c29919349
_d29919349